Definitive Healthcare Corp. (DH) — SEC Filings
Definitive Healthcare Corp. (DH) — 29 SEC filings. Latest: 8-K (May 7, 2026). Includes 12 8-K, 6 10-Q, 4 SC 13G/A.
View Definitive Healthcare Corp. on SEC EDGAR
Overview
Definitive Healthcare Corp. (DH) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 6, 2025: Definitive Healthcare Corp. reported a significant reduction in net loss for the three months ended September 30, 2025, narrowing to $17.79 million from $187.82 million in the prior year, primarily due to a substantial decrease in goodwill impairment charges. Revenue, however, declined by 4.2% to $6
Sentiment Summary
Across 29 filings, the sentiment breakdown is: 1 bearish, 25 neutral, 3 mixed. The dominant filing sentiment for Definitive Healthcare Corp. is neutral.
Filing Type Overview
Definitive Healthcare Corp. (DH) has filed 12 8-K, 1 DEFA14A, 6 10-Q, 2 DEF 14A, 1 10-K, 3 SC 13G, 4 SC 13G/A with the SEC between Jan 2024 to May 2026.
Filings by Year
Recent SEC Filings (29)
Risk Profile
Risk Assessment: Of DH's 19 recent filings, 0 were flagged as high-risk, 13 as medium-risk, and 6 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $60.05M |
| Net Income | -$17.79M |
| Cash Position | $108.32M |
| Total Assets | $755.53M |
| Total Debt | $166.94M |
Key Executives
- Jason Krantz
- Robert L. Johnson
- David M. Schneider
- Jason C. Cincotta
- Musslewhite
- Krantz
- Robert J. Musslewhite
- Robert F. W. Smith
- Robert M. L. Kelly
Industry Context
The healthcare analytics market is characterized by rapid technological advancement and increasing demand for data-driven insights. Definitive Healthcare operates in a competitive landscape with established players and emerging startups, all vying to provide solutions for navigating complex healthcare data. Key trends include the growing importance of AI and machine learning for predictive analytics and the ongoing consolidation within the health tech sector.
Top Tags
governance (5) · 10-Q (4) · executive-compensation (3) · financials (3) · institutional-ownership (3) · Healthcare Technology (2) · board-changes (2) · corporate-governance (2) · SEC filing (2) · Definitive Healthcare (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Revenue | $60.05M | Decreased from $62.70M in Q3 2024, a 4.2% decline. |
| Net Loss (Q3 2025) | $17.79M | Significantly improved from $187.82M in Q3 2024. |
| Net Loss (YTD Sep 2025) | $182.15M | Improved from $506.73M in YTD Sep 2024. |
| Goodwill Impairment (YTD Sep 2025) | $176.53M | Reduced from $591.79M in YTD Sep 2024. |
| Total Assets | $755.53M | Decreased from $1.09B at Dec 31, 2024. |
| Accumulated Deficit | $770.19M | Increased from $640.57M at Dec 31, 2024. |
| Class A Common Stock Outstanding | 103,303,387 | As of November 3, 2025. |
| Total Term Loan | $166.94M | Reduced from $243.12M at Dec 31, 2024. |
| Q2 2025 Revenue | $70.5M | Increased 11.5% from $63.2M in Q2 2024, showing consistent growth. |
| Q2 2025 Net Loss | -$1.8M | Significantly narrowed from -$10.1M in Q2 2024, indicating improved efficiency. |
| Revenue Growth Rate | 11.5% | Consistent year-over-year growth for both Q2 and the first six months of 2025. |
| H1 2025 Revenue | $139.1M | Up from $124.7M in H1 2024, demonstrating sustained top-line expansion. |
| H1 2025 Net Loss | -$10.2M | Improved from -$20.9M in H1 2024, reflecting a positive trend in profitability. |
| Cash & Equivalents | $200.5M | As of June 30, 2025, a decrease from $215.3M at year-end 2024. |
| Total Operating Expenses | $58.1M | For Q2 2025, an increase from $54.9M in Q2 2024, driven by investments. |
Forward-Looking Statements
- {"claim":"Other institutional investors may re-evaluate their positions in Definitive Healthcare Corp. following Echo Street Capital's complete divestment.","entity":"Definitive Healthcare Corp.","targetDate":"Q1 2024","confidence":"medium"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Definitive Healthcare Corp. (DH)?
Definitive Healthcare Corp. has 29 recent SEC filings from Jan 2024 to May 2026, including 12 8-K, 6 10-Q, 4 SC 13G/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of DH filings?
Across 29 filings, the sentiment breakdown is: 1 bearish, 25 neutral, 3 mixed. The dominant sentiment is neutral.
Where can I find Definitive Healthcare Corp. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Definitive Healthcare Corp. (DH) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Definitive Healthcare Corp.?
Key financial highlights from Definitive Healthcare Corp.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for DH?
The investment thesis for DH includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Definitive Healthcare Corp.?
Key executives identified across Definitive Healthcare Corp.'s filings include Jason Krantz, Robert L. Johnson, David M. Schneider, Jason C. Cincotta, Musslewhite and 4 others.
What are the main risk factors for Definitive Healthcare Corp. stock?
Of DH's 19 assessed filings, 0 were flagged high-risk, 13 medium-risk, and 6 low-risk.
What are recent predictions and forward guidance from Definitive Healthcare Corp.?
Recent forward-looking statements from Definitive Healthcare Corp. include guidance on {"claim":"Other institutional investors may re-evaluate their positions in Definitive Healthcare Corp. following Echo St.